|
ACE/Angiotension receptors
Citations 171-180 of 225 total displayed.
|
Past content
(since Jun 1999):
|
- Basic Science Reports
Angiotensin II Type 1 Receptor Blockade Prevents Lethal Malignant Hypertension: Relation to Kidney Inflammation
- Karl F. Hilgers, Andrea Hartner, Markus Porst, Roland Veelken, and Johannes F.E. Mann
Circulation 2001;104:1436-1440, doi:10.1161/hc3601.095576
[Abstract]
[Full text]
- Clinical Investigations and Reports
Point Mutation in the Stalk of Angiotensin-Converting Enzyme Causes a Dramatic Increase in Serum Angiotensin-Converting Enzyme But No Cardiovascular Disease
- Cornelis Kramers, Sergei M. Danilov, Jaap Deinum, Irina V. Balyasnikova, Nicole Scharenborg, Maaike Looman, Frans Boomsma, Marinus H. de Keijzer, Cornelia van Duijn, Sabrina Martin, Florent Soubrier, and Gosse J. Adema
Circulation 2001;104:1236-1240, doi:10.1161/hc3601.095932
[Abstract]
[Full text]
- Basic Science Reports
Cardioprotective Effects of Ramipril and Losartan in Right Ventricular Pressure Overload in the Rabbit: Importance of Kinins and Influence on Angiotensin II Type 1 Receptor Signaling Pathway
- Jean L. Rouleau, Gaston Kapuku, Stéphane Pelletier, Hugues Gosselin, Albert Adam, Caroline Gagnon, Chantal Lambert, and Sylvain Meloche
Circulation 2001;104:939-944, doi:10.1161/hc3401.093149
[Abstract]
[Full text]
- Brief Rapid Communications
Functional Evidence for a Role of Vascular Chymase in the Production of Angiotensin II in Isolated Human Arteries
- Vincent Richard, Sonia Hurel-Merle, Elizabeth Scalbert, Gilles Ferry, Françoise Lallemand, Jean-Paul Bessou, and Christian Thuillez
Circulation 2001;104:750-752, doi:10.1161/hc3201.094971
[Abstract]
[Full text]
- Current Perspectives
Microcirculation in Hypertension: A New Target for Treatment?
- B.I. Levy, G. Ambrosio, A.R. Pries, and H.A.J. Struijker-Boudier
Circulation 2001;104:735-740, doi:10.1161/hc3101.091158
[Full text]
- Correspondence
Giorgio Olivetti
- Paolo Madeddu
Circulation 2001;103:e134
[Full text]
- Basic Science Reports
Long-Term Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on Left Ventricular Collagen Deposition in Rats With 2-Kidney, 1-Clip Hypertension
- Nour-Eddine Rhaleb, Hongmei Peng, Xiao-Ping Yang, Yun-He Liu, Dharmesh Mehta, Eric Ezan, and Oscar A. Carretero
Circulation 2001;103:3136-3141
[Abstract]
[Full text]
- Basic Science Reports
Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure
- Luciano Dalla Libera, Barbara Ravara, Annalisa Angelini, Katia Rossini, Marco Sandri, Gaetano Thiene, Giovanni Battista Ambrosio, and Giorgio Vescovo
Circulation 2001;103:2195-2200
[Abstract]
[Full text]
- Clinical Investigations and Reports
Pharmacogenetic Interactions Between ß-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure
- Dennis M. McNamara, Richard Holubkov, Karen Janosko, Amy Palmer, Jue J. Wang, Guy A. MacGowan, Srinivas Murali, Warren D. Rosenblum, Barry London, and Arthur M. Feldman
Circulation 2001;103:1644-1648
[Abstract]
[Full text]
- Basic Science Reports
Genetic Variation in Angiotensin-Converting Enzyme Does Not Prevent Development of Cardiac Hypertrophy or Upregulation of Angiotensin II in Response to Aortocaval Fistula
- Gilbert J. Perry, Tatsuhiko Mori, Chih-Chang Wei, Xiao Yan Xu, Yiu-Fai Chen, Suzanne Oparil, Pamela Lucchesi, and Louis J. Dell’Italia
Circulation 2001;103:1012-1016
[Abstract]
[Full text]
|
|
